drugset / Trial / NCT03015324
Biological Effects of Agent on PAR-4 Levels With Resected Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
Hydroxychloroquine will be administered on an outpatient basis within 12 weeks after primary surgery followed by adjuvant chemotherapy /or radiation therapy (if needed). Hydroxychloroquine will be administered orally at a dose of 400 mg daily for 90 days. Subjects will receive HCQ every day.
Timeline
- Start
- 2017-08-08
- Primary completion
- 2020-02-03
- Completion
- 2021-02-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydroxychloroquine | Small molecule | 400 mg | Oral |